Health officials are drawing increased attention to alpha-gal syndrome, a potentially severe allergy to mammalian meat linked to tick bites. The condition, first identified about 15 years ago, has become more prevalent in recent years as cases continue to rise across the United States.

Alpha-gal syndrome occurs when the immune system reacts to a sugar molecule called galactose-alpha-1,3-galactose (alpha-gal), which is found in the meat of most mammals but not in humans or other primates. This sugar is also present in the saliva of certain tick species, notably the lone star tick, which is identified by a distinctive white spot on its back. When an infected tick bites a person, it can transfer alpha-gal directly into the bloodstream, prompting the immune system to produce antibodies against the sugar. This immune response can cause allergic reactions to meat and dairy products from cows, pigs, and lambs.

Unlike many tick-borne illnesses caused by bacteria or viruses, alpha-gal syndrome is driven by an immune reaction to a carbohydrate introduced through tick bites. Reactions typically do not occur immediately after ingesting meat but materialize several hours later, with symptoms ranging from hives, swelling, dizziness, and respiratory distress to gastrointestinal issues such as diarrhea and stomach pain. The severity and frequency of symptoms often escalate over time.

The syndrome affects an estimated 450,000 Americans, according to a 2023 study by the Centers for Disease Control and Prevention. Experts attribute the increasing number of cases to a combination of heightened awareness among healthcare providers and the public, as well as the expanding geographical range of the lone star tick. Traditionally found in the eastern and southern United States, this tick species has recently been reported in new areas, including the Great Lakes region and northern sites like Martha’s Vineyard, Massachusetts. Some researchers also warn that other tick species, such as the blacklegged tick, may start to contribute to the spread of alpha-gal syndrome.

Diagnosis is based on a combination of clinical symptoms, patient history—including recent tick bites—and blood tests detecting alpha-gal antibodies. However, not all individuals with positive antibody tests develop the allergy, and false positives can occur. Management of the syndrome has primarily centered on strict avoidance of mammalian meat and carrying an epinephrine injector for emergencies. Recently, regulatory approval was granted for the first drug specifically targeting alpha-gal syndrome, signaling progress toward new therapeutic options.

Researchers emphasize that poultry, eggs, and seafood are generally safe for individuals with the condition, as they do not contain the alpha-gal sugar. Awareness campaigns are ongoing to educate both the public and medical professionals about this unique allergic reaction and to promote preventive measures against tick bites.